Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults

S. Silberstein, P. Tfelt-Hansen, D. W. Dodick, V. Limmroth, R. B. Lipton, J. Pascual, S. J. Wang

Research output: Contribution to journalReview article

188 Scopus citations

Abstract

In 1991 the Clinical Trials Subcommittee of the International Headache Society (IHS) developed and published its first edition of the Guidelines on controlled trials of drugs in episodic migraine because only quality trials can form the basis for international collaboration on drug therapy, and these Guidelines would 'improve the quality of controlled clinical trials in migraine'. With the current trend for large multinational trials, there is a need for increased awareness of methodological issues in clinical trials of drugs and other treatments for chronic migraine. These Guidelines are intended to assist in the design of well-controlled clinical trials of chronic migraine in adults, and do not apply to studies in children or adolescents.

Original languageEnglish (US)
Pages (from-to)484-495
Number of pages12
JournalCephalalgia
Volume28
Issue number5
DOIs
StatePublished - May 1 2008

    Fingerprint

Keywords

  • Chronic migraine
  • Clinical trials
  • Headache
  • Medication-overuse headache
  • Prophylactic treatment

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Silberstein, S., Tfelt-Hansen, P., Dodick, D. W., Limmroth, V., Lipton, R. B., Pascual, J., & Wang, S. J. (2008). Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia, 28(5), 484-495. https://doi.org/10.1111/j.1468-2982.2008.01555.x